フローサイトメトリー市場 – 2033年までの世界予測

この調査レポートでは、フローサイトメトリー市場を、提供内容（試薬および消耗品、機器、サービス、ソフトウェア、アクセサリ）、テクノロジー（細胞ベースフローサイトメトリーおよびビーズベースフローサイトメトリー）、アプリケーション（研究アプリケーション、臨床アプリケーション、産業アプリケーション）、エンドユーザー（製薬およびバイオテクノロジー企業、病院および臨床検査研究所、学術研究機関）、および地域（北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ）別に分類しています。

本レポートは、フローサイトメトリー市場の成長に影響を与える主要な要因（促進要因、制約要因、課題、機会など）に関する詳細な情報を網羅しています。主要業界プレーヤーを徹底的に分析し、事業概要、ソリューション、サービス、主要戦略、新製品・新サービスの発売、買収、そしてフローサイトメトリー市場に関連する最近の動向に関する洞察を提供しています。本レポートは、フローサイトメトリー市場エコシステムにおける新興企業の競合分析を網羅しています。

世界のフローサイトメトリー市場は、2025年の50億6,000万米ドルから2033年には98億5,000万米ドルに達すると予測されており、予測期間中は年平均成長率（CAGR）8.7%で成長します。蛍光色素の結合や特異性の向上といった試薬技術の進歩は、市場を牽引する主要な要因の一つです。この分野は、細胞分析に不可欠な抗体、色素、その他の消耗品に対する継続的な需要により、市場を牽引しています。研究、臨床診断、医薬品開発におけるフローサイトメトリーの利用が拡大するにつれ、高品質な試薬に対する需要は依然として高い水準を維持しています。

The global flow cytometry market is estimated to reach USD 9.85 billion by 2033 from USD 5.06 billion in 2025, at a CAGR of 8.7% during the forecast period. Advancements in reagent technologies, such as fluorophore conjugation and specificity enhancement, are one of the major factors driving the market. This segment dominates due to continuous demand for antibodies, dyes, and other consumables essential for cell analysis. As the use of flow cytometry expands in research, clinical diagnostics, and drug development, the need for high-quality reagents remains constant.

“The cell-based flow cytometry market is likely to grow at a faster pace.”

Based on technology, the flow cytometry market is segmented into cell-based and bead-based flow cytometry. The cell-based flow cytometry segment dominated the market in 2024. The

dominance of cell-based flow cytometry in the technology segment is attributed to its

versatility in analyzing various cell types and biomarkers. Cell-based flow cytometry provides both quantitative and qualitative data that has increased its demand in biomedical research, clinical diagnostics, and drug discovery, thus driving its market significance.

“The research application dominated the applications market segment.”

Based on application, the flow cytometry market is segmented into research applications, clinical applications, and industrial applications. The research application dominated the segment; however, clinical application is anticipated to grow at a significant CAGR during the forecast period. The extensive use of flow cytometry in basic and translational research across diverse fields such as immunology, oncology, and microbiology is likely to drive the segmental growth.

“The market in Asia Pacific is estimated to witness the fastest growth rate.”

Based on region, the flow cytometry market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2024, North America accounted for a major share of the flow cytometry market. The Asia Pacific region is likely to grow at a significant CAGR during the forecast period, owing to various factors such as increasing investment in healthcare infrastructure, rising R&D activities in life sciences, and growing awareness about personalized medicine, which are driving this growth. Moreover, countries like China, Japan, India, and South Korea are witnessing substantial adoption of flow cytometry technologies in research, clinical diagnostics, and drug discovery.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Tier 1 – 25%, Tier 2 – 35%, and Tier 3 – 40%
• By Designation: C-level Executives – 30%, Directors – 45%, and Others – 25%
• By Region: North America – 35%, Europe – 25%, Asia Pacific – 15%, Latin America – 10%, Middle East – 10%, and Africa – 5%

List of Companies Profiled in the Report:

• Becton, Dickinson and Company (US)
• Danaher Corporation (US)
• Thermo Fisher Scientific Inc. (US)
• Agilent Technologies, Inc. (US)
• Sony Corporation (Japan)
• Bio-Rad Laboratories, Inc. (US)
• Miltenyi Biotec (Germany)
• Enzo Biochem, Inc. (US)
• Sysmex Corporation (Japan)
• bioMérieux (France)
• Cytonome/ST, LLC (US)
• Sartorius AG (Germany)
• Cytek Biosciences (US)
• Union Biometrica, Inc. (US)
• Takara Bio Inc. (Japan)

Research Coverage:

This research report categorizes flow cytometry market by Offering (Reagents and Consumables, Instruments, Services, Software, and Accessories), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Testing Laboratories, And Academic & Research Institutes), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).

The report’s scope covers detailed information regarding the primary factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the flow cytometry market. A thorough analysis of the key industry players has been conducted to provide insights into their business overview, solutions, and services; key strategies; new product & service launches, acquisitions, and recent developments associated with the flow cytometry market. This report covers the competitive analysis of upcoming startups in the flow cytometry market ecosystem.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the estimations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (Increasing prevalence of chronic diseases, growing use of flow cytometry in regenerative medicines, increasing collaborations, strategic partnerships, and alliances among key players, launch of technologically advanced flow cytometry products), restraints (High cost of advanced flow cytometers ), opportunities (Increased use in clinical applications and infectious disease diagnostics), and challenges (Complexities related to reagent development) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products and technological assessment of the flow cytometry market
• Market Development: Comprehensive information about lucrative markets and analysis of the market across varied regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the flow cytometry market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players, including Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, among others, offering products and services for flow cytometry market. Other companies include Apogee Flow Systems Ltd. (UK), Stratedigm, Inc. (US), NanoCellect Biomedical, Inc. (US), and On-chip Biotechnologies, Co., Ltd. (Japan), among others, for the flow cytometry market.

Table of Contents

1               INTRODUCTION              44

1.1           STUDY OBJECTIVES       44

1.2           MARKET DEFINITION   45

1.2.1        INCLUSIONS AND EXCLUSIONS 45

1.3           STUDY SCOPE   46

1.3.1        SEGMENTS COVERED    46

1.3.2        YEARS CONSIDERED      47

1.3.3        CURRENCY CONSIDERED            47

1.4           STAKEHOLDERS               47

1.5           SUMMARY OF CHANGES               48

2               RESEARCH METHODOLOGY       49

2.1           RESEARCH DATA              49

2.1.1        SECONDARY DATA          49

2.1.2        PRIMARY DATA 50

2.1.2.1    Breakdown of primaries      51

2.2           MARKET SIZE ESTIMATION         52

2.2.1        GLOBAL MARKET SIZE ESTIMATION      52

2.2.2        SEGMENTAL MARKET ASSESSMENT       55

2.3           MARKET GROWTH RATE PROJECTION  57

2.3.1        IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS             58

2.4           DATA TRIANGULATION                59

2.5           RESEARCH ASSUMPTIONS           60

2.6           RESEARCH LIMITATIONS             61

2.7           RISK ANALYSIS  61

3               EXECUTIVE SUMMARY  62

4               PREMIUM INSIGHTS       66

4.1           ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN FLOW CYTOMETRY MARKET   66

4.2           NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY  67

4.3           FLOW CYTOMETRY MARKET SHARE, BY END USER, 2024                 67

4.4           FLOW CYTOMETRY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              68

5               MARKET OVERVIEW       69

5.1           INTRODUCTION              69

5.2           MARKET DYNAMICS       69

5.2.1        DRIVERS               70

5.2.1.1    Increase in demand for flow cytometry in

oncology research & diagnostics        70

5.2.1.2    Growing use of flow cytometry in regenerative medicines                 71

5.2.1.3    Increasing collaborations, strategic partnerships, and alliances among key players                 72

5.2.1.4    Launch of technologically advanced flow cytometry products                 73

5.2.2        RESTRAINTS      74

5.2.2.1    High cost of advanced flow cytometers (analyzers & cell sorters)                 74

5.2.3        OPPORTUNITIES              75

5.2.3.1    Increased use in clinical applications and infectious disease diagnostics             75

5.2.4        CHALLENGES    75

5.2.4.1    Complexities related to reagent development  75

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            76

5.4           PRICING ANALYSIS          76

5.4.1        AVERAGE SELLING PRICE TREND OF FLOW CYTOMETRY PRODUCTS,

BY KEY PLAYER, 2022–2024            77

5.4.2        AVERAGE SELLING PRICE TREND OF FLOW CYTOMETRY PRODUCTS,

BY REGION, 2022–2024    79

5.5           VALUE CHAIN ANALYSIS               80

5.6           ECOSYSTEM ANALYSIS  82

5.6.1        INSTRUMENT & SOFTWARE PROVIDERS               82

5.6.2        REAGENT & CONSUMABLE PROVIDERS 82

5.6.3        END USERS         82

5.6.4        REGULATORY BODIES  82

5.7           REGULATORY ANALYSIS               84

5.7.1        REGULATORY LANDSCAPE         84

5.7.1.1    Stringent FDA requirements              84

5.7.1.2    Analyte-specific reagent rules             84

5.7.1.3    Limitations in validation protocols for cell-based assays                 85

5.7.1.4    Absence of test guidelines for cell-based fluorescence assays                 85

5.7.1.5    IVD CE mark approvals      85

5.7.2        LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           85

5.7.2.1    North America: List of regulatory bodies, government agencies,

and other organizations       85

5.7.2.2    Europe: List of regulatory bodies, government agencies,

and other organizations       86

5.7.2.3    Asia Pacific: List of regulatory bodies, government agencies,

and other organizations       87

5.7.2.4    Latin America: List of regulatory bodies, government agencies,

and other organizations       88

5.7.2.5    Middle East & Africa: List of regulatory bodies, government agencies, and other organizations      88

5.8           PORTER’S FIVE FORCES ANALYSIS           89

5.8.1        INTENSITY OF COMPETITIVE RIVALRY 90

5.8.2        BARGAINING POWER OF SUPPLIERS       90

5.8.3        BARGAINING POWER OF BUYERS             90

5.8.4        THREAT OF SUBSTITUTES          90

5.8.5        THREAT OF NEW ENTRANTS      91

5.9           KEY STAKEHOLDERS AND BUYING CRITERIA     91

5.9.1        KEY STAKEHOLDERS IN BUYING PROCESS           92

5.9.2        KEY BUYING CRITERIA  93

5.10         TECHNOLOGY ANALYSIS             94

5.10.1      KEY TECHNOLOGIES     94

5.10.1.1  Spectral flow cytometry       94

5.10.1.2  Mass cytometry     94

5.10.1.3  Imaging flow cytometry       95

5.10.2      ADJACENT TECHNOLOGIES       95

5.10.2.1  Single-cell RNA sequencing                95

5.10.2.2  Microfluidics         95

5.10.2.3  High-content screening       95

5.10.3      COMPLEMENTARY TECHNOLOGIES       96

5.10.3.1  Single-cell analysis                96

5.10.3.2  Spatial analysis      96

5.11         PATENT ANALYSIS          96

5.11.1      METHODOLOGY              96

5.11.2      PATENTS FILED, BY DOCUMENT TYPE, 2014−2024                 96

5.12         TRADE DATA ANALYSIS                98

5.12.1      IMPORT DATA  98

5.12.2      EXPORT DATA  99

5.13         INVESTMENT AND FUNDING SCENARIO               99

5.14         KEY CONFERENCES AND EVENTS, 2025–2026        101

5.15         IMPACT OF 2025 US TARIFF: FLOW CYTOMETRY MARKET               102

5.15.1      KEY TARIFF RATES          102

5.15.2      PRICE IMPACT ANALYSIS             104

5.15.3      KEY IMPACTS ON VARIOUS REGIONS     105

5.15.3.1  US           105

5.15.3.2  Europe   105

5.15.3.3  Asia Pacific            106

5.15.4      END-USE INDUSTRY IMPACT     106

5.15.4.1  Pharmaceutical and biotech companies            106

5.15.4.2  Hospitals & clinical laboratories         107

5.15.4.3  Academic & research institutes          107

5.16         IMPACT OF AI/GEN AI ON FLOW CYTOMETRY MARKET                 107

5.16.1      MARKET POTENTIAL OF AI IN FLOW CYTOMETRY                 107

5.16.2      AI USE CASES     108

5.16.3      KEY COMPANIES IMPLEMENTING AI/GEN AI      108

5.16.4      FUTURE OF AI/GEN AI IN FLOW CYTOMETRY MARKET                 108

6               FLOW CYTOMETRY MARKET, BY OFFERING       110

6.1           INTRODUCTION              111

6.2           REAGENTS & CONSUMABLES     111

6.2.1        ANTIBODIES      115

6.2.1.1    Increasing demand for high-specificity antibodies to propel market growth       115

6.2.2        ASSAYS & KITS   119

6.2.2.1    Need for high-precision diagnosis and advancements in personalized medicines to aid market growth  119

6.2.3        OTHER REAGENTS & CONSUMABLES     122

6.3           INSTRUMENTS 125

6.3.1        CELL ANALYZERS             129

6.3.1.1    High-range cell analyzers    133

6.3.1.1.1 Better sensitivity, accuracy, and flexibility in designing multicolor experiments to augment segment growth         133

6.3.1.2    Mid-range cell analyzers     136

6.3.1.2.1 Availability of compact and high-performance analyzers to support market growth        136

6.3.1.3    Low-range cell analyzers     139

6.3.1.3.1 Cost-effectiveness and increased commercialization by manufacturers to drive segment         139

6.3.2        CELL SORTERS  142

6.3.2.1    High-range cell sorters        146

6.3.2.1.1 High cost and budget constraints among end users to limit market growth    146

6.3.2.2    Mid-range cell sorters          149

6.3.2.2.1 Cost-effectiveness and high availability to spur market growth                 149

6.3.2.3    Low-range cell sorters          152

6.3.2.3.1 Increasing commercialization in small-scale laboratories and research facilities to fuel market growth           152

6.4           SERVICES             155

6.4.1        RISING FOCUS ON WORKFLOW CONTINUITY AND PERFORMANCE MAXIMIZATION TO BOOST MARKET GROWTH                 155

6.5           SOFTWARE         158

6.5.1        INCREASING AVAILABILITY OF DATA ANALYSIS SOFTWARE TO AID MARKET GROWTH  158

6.6           ACCESSORIES    162

6.6.1        HIGH AVAILABILITY OF ADVANCED AND CUSTOMIZED ACCESSORIES TO SUPPORT MARKET GROWTH 162

7               FLOW CYTOMETRY MARKET, BY TECHNOLOGY                 166

7.1           INTRODUCTION              167

7.2           CELL-BASED FLOW CYTOMETRY              167

7.2.1        INCREASED FOCUS ON R&D AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET GROWTH             167

7.3           BEAD-BASED FLOW CYTOMETRY             171

7.3.1        HIGHER RELIABILITY AND BETTER MEASUREMENT CONSISTENCIES TO SUPPORT MARKET GROWTH            171

8               FLOW CYTOMETRY MARKET, BY APPLICATION                 175

8.1           INTRODUCTION              176

8.2           RESEARCH APPLICATIONS          176

8.2.1        DRUG DISCOVERY AND DEVELOPMENT               180

8.2.1.1    Drug discovery      184

8.2.1.1.1 Growing use of phenotypic cell-based assays to support market growth    184

8.2.1.2    Stem cell research 188

8.2.1.2.1 Increasing R&D and rising investments for advanced stem cell development to drive segment            188

8.2.1.3    In vitro toxicity testing         192

8.2.1.3.1 Focus on continuous drug development by pharmaceutical & biotechnology companies to aid segment growth            192

8.2.2        IMMUNOLOGY 195

8.2.2.1    Growing prevalence of chronic autoimmune diseases to drive market    195

8.2.3        CELL SORTING 199

8.2.3.1    Increasing focus on cell-based research activities to fuel market growth    199

8.2.4        APOPTOSIS        203

8.2.4.1    Increased use in research activities to drive segment     203

8.2.5        CELL CYCLE ANALYSIS  206

8.2.5.1    High accuracy of cytometry products in cell analysis to propel segment growth    206

8.2.6        CELL VIABILITY                210

8.2.6.1    Growing use of cell viability assays in research to support market growth    210

8.2.7        CELL COUNTING             213

8.2.7.1    Rising need for multi-parametric cellular assessments to spur market growth       213

8.2.8        OTHER RESEARCH APPLICATIONS          217

8.3           CLINICAL APPLICATIONS            220

8.3.1        CANCER DIAGNOSTICS 224

8.3.1.1    Increasing prevalence of cancer to drive segment           224

8.3.2        HEMATOLOGY 228

8.3.2.1    Multi-parametric approach and high-speed cell analyzing capabilities to augment segment growth           228

8.3.3        AUTOIMMUNE DISEASES             231

8.3.3.1    Growing focus on developing treatments for autoimmune diseases to drive segment    231

8.3.4        ORGAN TRANSPLANTATION      235

8.3.4.1    Rising number of organ transplants to propel market growth                 235

8.3.5        OTHER CLINICAL APPLICATIONS             239

8.4           INDUSTRIAL APPLICATIONS      242

8.4.1        INCREASING USE IN FOOD, DAIRY, ENERGY, AND MICROBIAL INDUSTRIES TO SUPPORT MARKET GROWTH                 242

9               FLOW CYTOMETRY MARKET, BY END USER        247

9.1           INTRODUCTION              248

9.2           ACADEMIC & RESEARCH INSTITUTES    248

9.2.1        RISING PUBLIC-PRIVATE FUNDING AND INCREASING CANCER RESEARCH PROJECTS TO DRIVE MARKET          248

9.3           HOSPITALS & CLINICAL TESTING LABORATORIES                 253

9.3.1        GROWING DEMAND FOR EFFECTIVE DISEASE DIAGNOSIS AND TREATMENT TO SPUR MARKET GROWTH                 253

9.4           PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 257

9.4.1        INCREASING FOCUS ON PERSONALIZED MEDICINE AND TARGETED THERAPIES TO FUEL MARKET GROWTH                 257

10            FLOW CYTOMETRY MARKET, BY REGION             261

10.1         INTRODUCTION              262

10.2         NORTH AMERICA             263

10.2.1      MACROECONOMIC OUTLOOK  263

10.2.2      US           269

10.2.2.1  US to dominate North American flow cytometry market during study period           269

10.2.3      CANADA               274

10.2.3.1  Ongoing government initiatives for life science research and high incidence of cancer to propel market growth   274

10.3         EUROPE               279

10.3.1      MACROECONOMIC OUTLOOK  280

10.3.2      GERMANY           286

10.3.2.1  Increasing public and private funding for advanced cell-based research activities to aid market growth            286

10.3.3      UK          290

10.3.3.1  Growing acceptance of flow cytometry-based diagnostic techniques by healthcare professionals to spur market growth     290

10.3.4      FRANCE                295

10.3.4.1  Increasing government funding for proteomics and genomics research to fuel market growth           295

10.3.5      ITALY    301

10.3.5.1  Large geriatric population and presence of well-developed healthcare system to boost market growth       301

10.3.6      SPAIN    305

10.3.6.1  High incidence of cancer and focus on translational and personalized medicines to augment market growth        305

10.3.7      REST OF EUROPE             310

10.4         ASIA PACIFIC     316

10.4.1      MACROECONOMIC OUTLOOK  316

10.4.2      CHINA  322

10.4.2.1  High incidence of cancer and favorable government policies to support market growth        322

10.4.3      JAPAN   327

10.4.3.1  Technological advancements and high prevalence of chronic diseases to drive market      327

10.4.4      INDIA    332

10.4.4.1  Rising government funding for proteomics research to drive market    332

10.4.5      AUSTRALIA         338

10.4.5.1  Increasing government research funding and growing prevalence of cancer to propel market growth     338

10.4.6      SOUTH KOREA  343

10.4.6.1  Rising number of conferences and growing focus on medical research to spur market growth          343

10.4.7      SINGAPORE        348

10.4.7.1  Increasing availability of data analysis software and growing focus on medical tourism to drive market   348

10.4.8      INDONESIA        354

10.4.8.1  Rising prevalence of HIV and cancer to drive market    354

10.4.9      REST OF ASIA PACIFIC   359

10.5         LATIN AMERICA                364

10.5.1      MACROECONOMIC OUTLOOK  365

10.5.2      BRAZIL 370

10.5.2.1  Presence of key market players and increased emphasis on cancer research to boost market growth        370

10.5.3      MEXICO                375

10.5.3.1  Favorable trade agreements and growth of pharmaceutical industry to fuel market growth           375

10.5.4      REST OF LATIN AMERICA             380

10.6         MIDDLE EAST   385

10.6.1      MACROECONOMIC OUTLOOK  385

10.6.2      GCC COUNTRIES              391

10.6.2.1  Saudi Arabia          395

10.6.2.1.1                Growing prevalence of chronic diseases and increasing R&D investments to boost market growth       395

10.6.2.2  UAE        400

10.6.2.2.1                Increased R&D investment and favorable government healthcare policies to drive market    400

10.6.2.3  Rest of GCC countries         405

10.6.3      REST OF MIDDLE EAST 410

10.7         AFRICA 416

10.7.1      INCREASING BURDEN OF INFECTIOUS AND NON-COMMUNICABLE DISEASES TO PROPEL MARKET GROWTH                 416

10.7.2      MACROECONOMIC OUTLOOK  416

11            COMPETITIVE LANDSCAPE         422

11.1         OVERVIEW          422

11.2         KEY PLAYER STRATEGY/RIGHT TO WIN                422

11.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN FLOW CYTOMETRY MARKET                422

11.3         REVENUE ANALYSIS       424

11.4         MARKET SHARE ANALYSIS           425

11.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 427

11.5.1      STARS   427

11.5.2      EMERGING LEADERS     427

11.5.3      PERVASIVE PLAYERS      427

11.5.4      PARTICIPANTS 427

11.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         429

11.5.5.1  Company footprint               429

11.5.5.2  Product & service footprint 430

11.5.5.3  Region footprint   431

11.5.5.4  Application footprint            432

11.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        432

11.6.1      PROGRESSIVE COMPANIES         432

11.6.2      RESPONSIVE COMPANIES            432

11.6.3      DYNAMIC COMPANIES  433

11.6.4      STARTING BLOCKS         433

11.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 434

11.7         VALUATION & FINANCIAL METRICS       436

11.7.1      VALUATION OF KEY PLAYERS    436

11.7.2      FINANCIAL METRICS OF KEY PLAYERS  436

11.8         BRAND/PRODUCT COMPARISON             437

11.9         COMPETITIVE SCENARIO             439

11.9.1      PRODUCT LAUNCHES & APPROVALS     439

11.9.2      DEALS  440

12            COMPANY PROFILES      441

12.1         KEY PLAYERS     441

12.1.1      BECTON, DICKINSON AND COMPANY   441

12.1.1.1  Business overview 441

12.1.1.2  Products/Services offered   442

12.1.1.3  Recent developments           446

12.1.1.3.1                Product launches  446

12.1.1.3.2                Deals      447

12.1.1.4  MnM view              447

12.1.1.4.1                Right to win           447

12.1.1.4.2                Strategic choices   447

12.1.1.4.3                Weaknesses & competitive threats     448

12.1.2      DANAHER CORPORATION           449

12.1.2.1  Business overview 449

12.1.2.2  Products/Services offered   451

12.1.2.3  Recent developments           453

12.1.2.3.1                Product launches  453

12.1.2.3.2                Deals      453

12.1.2.4  MnM view              454

12.1.2.4.1                Right to win           454

12.1.2.4.2                Strategic choices   454

12.1.2.4.3                Weaknesses & competitive threats     454

12.1.3      THERMO FISHER SCIENTIFIC INC.            455

12.1.3.1  Business overview 455

12.1.3.2  Products/Services offered   456

12.1.3.3  Recent developments           457

12.1.3.3.1                Product launches  457

12.1.3.3.2                Deals      458

12.1.3.4  MnM view              458

12.1.3.4.1                Right to win           458

12.1.3.4.2                Strategic choices   458

12.1.3.4.3                Weaknesses & competitive threats     458

12.1.4      AGILENT TECHNOLOGIES, INC.                459

12.1.4.1  Business overview 459

12.1.4.2  Products/Services offered   461

12.1.4.3  Recent developments           462

12.1.4.3.1                Product launches  462

12.1.5      SONY CORPORATION    463

12.1.5.1  Business overview 463

12.1.5.2  Products/Services offered   464

12.1.5.3  Recent developments           466

12.1.5.3.1                Product launches  466

12.1.5.3.2                Deals      466

12.1.6      BIO-RAD LABORATORIES, INC.  467

12.1.6.1  Business overview 467

12.1.6.2  Products/Services/Solutions offered 468

12.1.6.3  Recent developments           469

12.1.6.3.1                Product launches  469

12.1.7      MILTENYI BIOTEC           470

12.1.7.1  Business overview 470

12.1.7.2  Products/Services offered   470

12.1.8      ENZO BIOCHEM INC.     472

12.1.8.1  Business overview 472

12.1.8.2  Products/Services offered   473

12.1.9      SYSMEX CORPORATION                475

12.1.9.1  Business overview 475

12.1.9.2  Products/Services offered   477

12.1.9.3  Recent developments           477

12.1.9.3.1                Product launches  477

12.1.10   CYTEK BIOSCIENCES     478

12.1.10.1                 Business overview 478

12.1.10.2                 Products/Services offered   480

12.1.10.3                 Recent developments           481

12.1.10.3.1             Product launches  481

12.1.10.3.2             Deals      481

12.1.11   BIOMÉRIEUX     483

12.1.11.1                 Business overview 483

12.1.11.2                 Products/Services offered   484

12.1.12   CYTONOME/ST, LLC      485

12.1.12.1                 Business overview 485

12.1.12.2                 Products/Services offered   485

12.1.13   SARTORIUS AG 486

12.1.13.1                 Business overview 486

12.1.13.2                 Products/Services offered   487

12.1.14   UNION BIOMETRICA, INC.           488

12.1.14.1                 Business overview 488

12.1.14.2                 Products/Services offered   488

12.1.15   TAKARA BIO INC.             489

12.1.15.1                 Business overview 489

12.1.15.2                 Products/Services offered   491

12.2         OTHER PLAYERS              492

12.2.1      APOGEE FLOW SYSTEMS LTD.   492

12.2.2      STRATEDIGM, INC.          493

12.2.3      NANOCELLECT BIOMEDICAL    494

12.2.4      BIOLEGEND, INC.             495

12.2.5      ON-CHIP BIOTECHNOLOGIES CO., LTD.               496

12.2.6      NEXCELOM BIOSCIENCE LLC     497

12.2.7      BENNUBIO INC.                498

12.2.8      ORFLO TECHNOLOGIES               499

12.2.9      BAY BIOSCIENCE LLC     500

12.2.10   CYTOBUOY        500

13            APPENDIX           501

13.1         DISCUSSION GUIDE        501

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                507

13.3         CUSTOMIZATION OPTIONS        509

13.4         RELATED REPORTS         509

13.5         AUTHOR DETAILS           510

LIST OF TABLES

TABLE 1                FLOW CYTOMETRY MARKET: INCLUSIONS AND EXCLUSIONS      45

TABLE 2                IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS IN

FLOW CYTOMETRY MARKET      58

TABLE 3                FLOW CYTOMETRY MARKET: RISK ANALYSIS                 61

TABLE 4                INCIDENCE OF HIV/AIDS GLOBALLY, BY REGION, 2023     70

TABLE 5                GLOBAL INCIDENCE OF CANCER, BY REGION, 2022        70

TABLE 6                ESTIMATED EXPENDITURE BY NATIONAL INSTITUTES OF HEALTH FOR

STEM CELL RESEARCH, 2019–2024              72

TABLE 7                KEY PRODUCT LAUNCHES IN FLOW CYTOMETRY MARKET,

JANUARY 2021–MAY 2025               73

TABLE 8                AVERAGE SELLING PRICE TREND OF FLOW CYTOMETRY PRODUCTS,

BY KEY PLAYER, 2022–2024 (USD MILLION)           77

TABLE 9                AVERAGE SELLING PRICE TREND OF FLOW CYTOMETRY REAGENTS

AND CONSUMABLES, BY REGION, 2022–2024 (USD MILLION)                 79

TABLE 10              AVERAGE SELLING PRICE TREND OF FLOW CYTOMETRY INSTRUMENTS,

BY REGION, 2022–2024 (USD MILLION)   79

TABLE 11              FLOW CYTOMETRY MARKET: ROLE IN ECOSYSTEM       83

TABLE 12              NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT

AGENCIES, AND OTHER ORGANIZATIONS           85

TABLE 13              EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  86

TABLE 14              ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  87

TABLE 15             LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  88

TABLE 16              MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             88

TABLE 17              FLOW CYTOMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS           89

TABLE 18              INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS            92

TABLE 19              KEY BUYING CRITERIA, BY END USER    93

TABLE 20              PATENTS FILED (2014−2024)      96

TABLE 21              PATENTS IN FLOW CYTOMETRY MARKET                 97

TABLE 22              IMPORT VALUE OF HS CODE 9027.50–COMPLIANT PRODUCTS FOR

TOP 20 COUNTRIES, 2020–2024 (USD THOUSAND)            98

TABLE 23              EXPORT VALUE OF HS CODE 9027.50 – COMPLIANT PRODUCTS FOR

TOP 20 COUNTRIES, 2020–2024 (USD THOUSAND)            99

TABLE 24              MAJOR INVESTMENT AND FUNDING ACTIVITIES IN

FLOW CYTOMETRY MARKET, 2022–2025                 100

TABLE 25              FLOW CYTOMETRY MARKET: LIST OF KEY CONFERENCES AND EVENTS,

JANUARY 2025–DECEMBER 2026 101

TABLE 26              US ADJUSTED RECIPROCAL TARIFF RATES                 102

TABLE 27              EXPORTS AND IMPORTS, BY REGION     103

TABLE 28              KEY PRODUCT-RELATED TARIFF: INSTRUMENTS AND APPARATUS; PARTS AND ACCESSORIES THEREOF, MISCELLANEOUS CHEMICAL PRODUCTS       104

TABLE 29              CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES            105

TABLE 30              LIST OF COMPANIES IMPLEMENTING AI/GEN AI IN FLOW CYTOMETRY MARKET                108

TABLE 31              FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION)            111

TABLE 32              FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE,

2023–2033 (USD MILLION)            112

TABLE 33              FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY REGION,

2023–2033 (USD MILLION)            112

TABLE 34              NORTH AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2023–2033 (USD MILLION) 113

TABLE 35              EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY COUNTRY, 2023–2033 (USD MILLION)               113

TABLE 36              ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY COUNTRY, 2023–2033 (USD MILLION)               114

TABLE 37              LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY COUNTRY, 2023–2033 (USD MILLION)               114

TABLE 38              MIDDLE EAST: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY COUNTRY, 2023–2033 (USD MILLION)               114

TABLE 39              GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2023–2033 (USD MILLION) 115

TABLE 40              ANTIBODIES MARKET, BY REGION, 2023–2033 (USD MILLION) 116

TABLE 41              NORTH AMERICA: ANTIBODIES MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     116

TABLE 42              EUROPE: ANTIBODIES MARKET, BY COUNTRY, 2023–2033 (USD MILLION)            117

TABLE 43              ASIA PACIFIC: ANTIBODIES MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     117

TABLE 44              LATIN AMERICA: ANTIBODIES MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     118

TABLE 45              MIDDLE EAST: ANTIBODIES MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     118

TABLE 46              GCC COUNTRIES: ANTIBODIES MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     118

TABLE 47              ASSAYS & KITS MARKET, BY REGION, 2023–2033 (USD MILLION) 119

TABLE 48              NORTH AMERICA: ASSAYS & KITS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            120

TABLE 49              EUROPE: ASSAYS & KITS MARKET, BY COUNTRY, 2023–2033 (USD MILLION)            120

TABLE 50              ASIA PACIFIC: ASSAYS & KITS MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     120

TABLE 51              LATIN AMERICA: ASSAYS & KITS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            121

TABLE 52              MIDDLE EAST: ASSAYS & KITS MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     121

TABLE 53              GCC COUNTRIES: ASSAYS & KITS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            121

TABLE 54              OTHER REAGENTS & CONSUMABLES MARKET, BY REGION,

2023–2033 (USD MILLION)            122

TABLE 55              NORTH AMERICA: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2023–2033 (USD MILLION)            123

TABLE 56              EUROPE: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            123

TABLE 57              ASIA PACIFIC: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            124

TABLE 58              LATIN AMERICA: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2023–2033 (USD MILLION)            124

TABLE 59              MIDDLE EAST: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2023–2033 (USD MILLION)            124

TABLE 60              GCC COUNTRIES: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2023–2033 (USD MILLION)            125

TABLE 61              FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            126

TABLE 62              FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY REGION,

2023–2033 (USD MILLION)            126

TABLE 63              NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2033 (USD MILLION)                 126

TABLE 64              EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY,

2023–2033 (USD MILLION)            127

TABLE 65              ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2033 (USD MILLION)                 127

TABLE 66              LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2033 (USD MILLION)                 128

TABLE 67              MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2033 (USD MILLION)                 128

TABLE 68              GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2033 (USD MILLION)                 128

TABLE 69              CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            130

TABLE 70              CELL ANALYZERS MARKET, BY REGION, 2023–2033 (USD MILLION)       130

TABLE 71              NORTH AMERICA: CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            130

TABLE 72              EUROPE: CELL ANALYZERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     131

TABLE 73              ASIA PACIFIC: CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            131

TABLE 74              LATIN AMERICA: CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            132

TABLE 75              MIDDLE EAST: CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            132

TABLE 76              GCC COUNTRIES: CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            132

TABLE 77              HIGH-RANGE CELL ANALYZERS MARKET, BY REGION, 2023–2033 (USD MILLION)          133

TABLE 78              NORTH AMERICA: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            133

TABLE 79              EUROPE: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            134

TABLE 80              ASIA PACIFIC: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            134

TABLE 81              LATIN AMERICA: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            135

TABLE 82              MIDDLE EAST: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            135

TABLE 83              GCC COUNTRIES: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            135

TABLE 84              MID-RANGE CELL ANALYZERS MARKET, BY REGION, 2023–2033 (USD MILLION)          136

TABLE 85              NORTH AMERICA: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            136

TABLE 86              EUROPE: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            137

TABLE 87              ASIA PACIFIC: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            137

TABLE 88              LATIN AMERICA: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            138

TABLE 89              MIDDLE EAST: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            138

TABLE 90              GCC COUNTRIES: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            138

TABLE 91              LOW-RANGE CELL ANALYZERS MARKET, BY REGION, 2023–2033 (USD MILLION)          139

TABLE 92              NORTH AMERICA: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            139

TABLE 93              EUROPE: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            140

TABLE 94              ASIA PACIFIC: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            140

TABLE 95              LATIN AMERICA: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            141

TABLE 96              MIDDLE EAST: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            141

TABLE 97              GCC COUNTRIES: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            141

TABLE 98              LIST OF KEY CELL SORTERS AVAILABLE IN MARKET               142

TABLE 99              CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)       143

TABLE 100            CELL SORTERS MARKET, BY REGION, 2023–2033 (USD MILLION  143

TABLE 101            NORTH AMERICA: CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            143

TABLE 102          EUROPE: CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION)            144

TABLE 103            ASIA PACIFIC: CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     144

TABLE 104            LATIN AMERICA: CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            145

TABLE 105            MIDDLE EAST: CELL SORTERS MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     145

TABLE 106            GCC COUNTRIES: CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            145

TABLE 107            HIGH-RANGE CELL SORTERS MARKET, BY REGION, 2023–2033 (USD MILLION)          146

TABLE 108            NORTH AMERICA: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            146

TABLE 109            EUROPE: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            147

TABLE 110            ASIA PACIFIC: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            147

TABLE 111            LATIN AMERICA: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            148

TABLE 112            MIDDLE EAST: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            148

TABLE 113            GCC COUNTRIES: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            148

TABLE 114            MID-RANGE CELL SORTERS MARKET, BY REGION, 2023–2033 (USD MILLION)          149

TABLE 115            NORTH AMERICA: MID-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            149

TABLE 116            EUROPE: MID-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            150

TABLE 117            ASIA PACIFIC: MID-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            150

TABLE 118            LATIN AMERICA: MID-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            151

TABLE 119            MIDDLE EAST: MID-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            151

TABLE 120            GCC COUNTRIES: MID-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            151

TABLE 121            LOW-RANGE CELL SORTERS MARKET, BY REGION, 2023–2033 (USD MILLION)          152

TABLE 122            NORTH AMERICA: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            152

TABLE 123            EUROPE: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            153

TABLE 124            ASIA PACIFIC: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            153

TABLE 125            LATIN AMERICA: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            154

TABLE 126            MIDDLE EAST: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            154

TABLE 127            GCC COUNTRIES: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            154

TABLE 128            FLOW CYTOMETRY MARKET FOR SERVICES, BY REGION,

2023–2033 (USD MILLION)            155

TABLE 129            NORTH AMERICA: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2023–2033 (USD MILLION)                 156

TABLE 130            EUROPE: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY,

2023–2033 (USD MILLION)            156

TABLE 131            ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY,

2023–2033 (USD MILLION)            157

TABLE 132            LATIN AMERICA: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY,

2023–2033 (USD MILLION)            157

TABLE 133            MIDDLE EAST: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY,

2023–2033 (USD MILLION)            158

TABLE 134            GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2023–2033 (USD MILLION)                 158

TABLE 135            FLOW CYTOMETRY MARKET FOR SOFTWARE, BY REGION,

2023–2033 (USD MILLION)            159

TABLE 136            NORTH AMERICA: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2023–2033 (USD MILLION)                 160

TABLE 137            EUROPE: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY,

2023–2033 (USD MILLION)            160

TABLE 138            ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY,

2023–2033 (USD MILLION)            161

TABLE 139            LATIN AMERICA: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2023–2033 (USD MILLION)                 161

TABLE 140            MIDDLE EAST: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY,

2023–2033 (USD MILLION)            162

TABLE 141            GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2023–2033 (USD MILLION)                 162

TABLE 142          FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY REGION,

2023–2033 (USD MILLION)            163

TABLE 143            NORTH AMERICA: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2033 (USD MILLION)                 163

TABLE 144            EUROPE: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY,

2023–2033 (USD MILLION)            164

TABLE 145            ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2033 (USD MILLION) 164

TABLE 146            LATIN AMERICA: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2033 (USD MILLION)                 165

TABLE 147            MIDDLE EAST: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2033 (USD MILLION)                 165

TABLE 148            GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2023–2033 (USD MILLION)                 165

TABLE 149          FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION)            167

TABLE 150            CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2023–2033 (USD MILLION)          168

TABLE 151            NORTH AMERICA: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            168

TABLE 152            EUROPE: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            169

TABLE 153            ASIA PACIFIC: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            169

TABLE 154            LATIN AMERICA: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            170

TABLE 155            MIDDLE EAST: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            170

TABLE 156            GCC COUNTRIES: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION))           170

TABLE 157            BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2023–2033 (USD MILLION)          172

TABLE 158            NORTH AMERICA: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            172

TABLE 159            EUROPE: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            173

TABLE 160            ASIA PACIFIC: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            173

TABLE 161            LATIN AMERICA: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            174

TABLE 162            MIDDLE EAST: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            174

TABLE 163            GCC COUNTRIES: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            174

TABLE 164            FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION)            176

TABLE 165            FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2033 (USD MILLION)            177

TABLE 166            FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION,

2023–2033 (USD MILLION)            177

TABLE 167            NORTH AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               178

TABLE 168            EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               178

TABLE 169            ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               179

TABLE 170            LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               179

TABLE 171            MIDDLE EAST: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               180

TABLE 172            GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               180

TABLE 173            DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            181

TABLE 174            DRUG DISCOVERY AND DEVELOPMENT MARKET, BY REGION,

2023–2033 (USD MILLION)            181

TABLE 175            NORTH AMERICA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY COUNTRY, 2023–2033 (USD MILLION)            181

TABLE 176            EUROPE: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            182

TABLE 177            ASIA PACIFIC: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY COUNTRY, 2023–2033 (USD MILLION)            182

TABLE 178            LATIN AMERICA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY COUNTRY, 2023–2033 (USD MILLION)            183

TABLE 179            MIDDLE EAST: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY COUNTRY, 2023–2033 (USD MILLION)            183

TABLE 180            GCC COUNTRIES: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY COUNTRY, 2023–2033 (USD MILLION)            183

TABLE 181            DRUG DISCOVERY MARKET, BY REGION, 2023–2033 (USD MILLION)       185

TABLE 182            NORTH AMERICA: DRUG DISCOVERY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            185

TABLE 183            EUROPE: DRUG DISCOVERY MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     186

TABLE 184            ASIA PACIFIC: DRUG DISCOVERY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            186

TABLE 185            LATIN AMERICA: DRUG DISCOVERY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            187

TABLE 186            MIDDLE EAST: DRUG DISCOVERY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            187

TABLE 187            GCC COUNTRIES: DRUG DISCOVERY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            187

TABLE 188            STEM CELL RESEARCH MARKET, BY REGION, 2023–2033 (USD MILLION)            189

TABLE 189            NORTH AMERICA: STEM CELL RESEARCH MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            189

TABLE 190            EUROPE: STEM CELL RESEARCH MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            190

TABLE 191            ASIA PACIFIC: STEM CELL RESEARCH MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            190

TABLE 192            LATIN AMERICA: STEM CELL RESEARCH MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            191

TABLE 193            MIDDLE EAST: STEM CELL RESEARCH MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            191

TABLE 194            GCC COUNTRIES: STEM CELL RESEARCH MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            191

TABLE 195            IN VITRO TOXICITY TESTING MARKET, BY REGION, 2023–2033 (USD MILLION)          192

TABLE 196            NORTH AMERICA: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            193

TABLE 197          EUROPE: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            193

TABLE 198            ASIA PACIFIC: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            194

TABLE 199            LATIN AMERICA: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            194

TABLE 200            MIDDLE EAST: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            195

TABLE 201            IMMUNOLOGY MARKET, BY REGION, 2023–2033 (USD MILLION) 196

TABLE 202            NORTH AMERICA: IMMUNOLOGY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            196

TABLE 203            EUROPE: IMMUNOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     197

TABLE 204            GCC COUNTRIES: IN VITRO TESTING MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            197

TABLE 205            ASIA PACIFIC: IMMUNOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     198

TABLE 206            LATIN AMERICA: IMMUNOLOGY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            198

TABLE 207            MIDDLE EAST: IMMUNOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     198

TABLE 208            GCC COUNTRIES: IMMUNOLOGY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            199

TABLE 209            CELL SORTING MARKET, BY REGION, 2023–2033 (USD MILLION) 200

TABLE 210            NORTH AMERICA: CELL SORTING MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            200

TABLE 211            EUROPE: CELL SORTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     201

TABLE 212            ASIA PACIFIC: CELL SORTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     201

TABLE 213            LATIN AMERICA: CELL SORTING MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            202

TABLE 214            MIDDLE EAST: CELL SORTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     202

TABLE 215            GCC COUNTRIES: CELL SORTING MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            202

TABLE 216            APOPTOSIS MARKET, BY REGION, 2023–2033 (USD MILLION) 203

TABLE 217            NORTH AMERICA: APOPTOSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     204

TABLE 218            EUROPE: APOPTOSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION)            204

TABLE 219            ASIA PACIFIC: APOPTOSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     205

TABLE 220            LATIN AMERICA: APOPTOSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     205

TABLE 221            MIDDLE EAST: APOPTOSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     206

TABLE 222            GCC COUNTRIES: APOPTOSIS MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     206

TABLE 223            CELL CYCLE ANALYSIS MARKET, BY REGION, 2023–2033 (USD MILLION)            207

TABLE 224            NORTH AMERICA: CELL CYCLE ANALYSIS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            207

TABLE 225            EUROPE: CELL CYCLE ANALYSIS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            208

TABLE 226            ASIA PACIFIC: CELL CYCLE ANALYSIS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            208

TABLE 227            LATIN AMERICA: CELL CYCLE ANALYSIS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            209

TABLE 228            MIDDLE EAST: CELL CYCLE ANALYSIS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            209

TABLE 229            GCC COUNTRIES: CELL CYCLE ANALYSIS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            209

TABLE 230            CELL VIABILITY MARKET, BY REGION, 2023–2033 (USD MILLION) 210

TABLE 231            NORTH AMERICA: CELL VIABILITY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            211

TABLE 232            EUROPE: CELL VIABILITY MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     211

TABLE 233            ASIA PACIFIC: CELL VIABILITY MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     212

TABLE 234            LATIN AMERICA: CELL VIABILITY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            212

TABLE 235            MIDDLE EAST: CELL VIABILITY MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     213

TABLE 236            GCC COUNTRIES: CELL VIABILITY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            213

TABLE 237            CELL COUNTING MARKET, BY REGION, 2023–2033 (USD MILLION)       214

TABLE 238            NORTH AMERICA: CELL COUNTING MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            214

TABLE 239            EUROPE: CELL COUNTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     215

TABLE 240            ASIA PACIFIC: CELL COUNTING MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     215

TABLE 241            LATIN AMERICA: CELL COUNTING MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            216

TABLE 242            MIDDLE EAST: CELL COUNTING MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            216

TABLE 243            GCC COUNTRIES: CELL COUNTING MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            216

TABLE 244            OTHER RESEARCH APPLICATIONS MARKET, BY REGION,

2023–2033 (USD MILLION)            217

TABLE 245            NORTH AMERICA: OTHER RESEARCH APPLICATIONS MARKET,

BY COUNTRY, 2023–2033 (USD MILLION)               217

TABLE 246            EUROPE: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            218

TABLE 247            ASIA PACIFIC: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            218

TABLE 248            LATIN AMERICA: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            219

TABLE 249            MIDDLE EAST: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            219

TABLE 250            GCC COUNTRIES: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            219

TABLE 251            FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE,

2023–2033 (USD MILLION)            220

TABLE 252            FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION,

2023–2033 (USD MILLION)            221

TABLE 253            NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               221

TABLE 254            EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2023–2033 (USD MILLION)            222

TABLE 255            ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               222

TABLE 256            LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               223

TABLE 257            MIDDLE EAST: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               223

TABLE 258            GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               223

TABLE 259            ESTIMATED NUMBER OF NEW CANCER CASES (2020–2040)          224

TABLE 260            CANCER DIAGNOSTICS MARKET, BY REGION, 2023–2033 (USD MILLION)            225

TABLE 261            NORTH AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            225

TABLE 262            EUROPE: CANCER DIAGNOSTICS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            226

TABLE 263            ASIA PACIFIC: CANCER DIAGNOSTICS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            226

TABLE 264            LATIN AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            227

TABLE 265            MIDDLE EAST: CANCER DIAGNOSTICS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            227

TABLE 266            GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CANCER, BY COUNTRY,

2023–2033 (USD MILLION)            227

TABLE 267            HEMATOLOGY MARKET, BY REGION, 2023–2033 (USD MILLION) 228

TABLE 268            NORTH AMERICA: HEMATOLOGY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            229

TABLE 269            EUROPE: HEMATOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     229

TABLE 270            ASIA PACIFIC: HEMATOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     230

TABLE 271            LATIN AMERICA: HEMATOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     230

TABLE 272            MIDDLE EAST: HEMATOLOGY MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     230

TABLE 273            GCC COUNTRIES: HEMATOLOGY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            231

TABLE 274            AUTOIMMUNE DISEASES MARKET, BY REGION, 2023–2033 (USD MILLION)            232

TABLE 275            NORTH AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            232

TABLE 276            EUROPE: AUTOIMMUNE DISEASES MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            233

TABLE 277            ASIA PACIFIC: AUTOIMMUNE DISEASES MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            233

TABLE 278            LATIN AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            234

TABLE 279            MIDDLE EAST: AUTOIMMUNE DISEASES MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            234

TABLE 280            GCC COUNTRIES: AUTOIMMUNE DISEASES MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            234

TABLE 281            ORGAN TRANSPLANTATION MARKET, BY REGION, 2023–2033 (USD MILLION)          236

TABLE 282            NORTH AMERICA: ORGAN TRANSPLANTATION MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            236

TABLE 283            EUROPE: ORGAN TRANSPLANTATION MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            237

TABLE 284            ASIA PACIFIC: ORGAN TRANSPLANTATION MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            237

TABLE 285            LATIN AMERICA: ORGAN TRANSPLANTATION MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            238

TABLE 286            MIDDLE EAST: ORGAN TRANSPLANTATION MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            238

TABLE 287            GCC COUNTRIES: ORGAN TRANSPLANTATION MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            238

TABLE 288            OTHER CLINICAL APPLICATIONS MARKET, BY REGION, 2023–2033 (USD MILLION)          239

TABLE 289            NORTH AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            240

TABLE 290            EUROPE: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            240

TABLE 291            ASIA PACIFIC: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            241

TABLE 292            LATIN AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            241

TABLE 293            MIDDLE EAST: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            242

TABLE 294            GCC COUNTRIES: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY,

2023–2033 (USD MILLION)          242

TABLE 295            FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION,

2023–2033 (USD MILLION)            243

TABLE 296            NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               244

TABLE 297            EUROPE: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               244

TABLE 298            ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               245

TABLE 299            LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               245

TABLE 300            MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               246

TABLE 301            GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS,

BY COUNTRY, 2023–2033 (USD MILLION)               246

TABLE 302            FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION)            248

TABLE 303            FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2033 (USD MILLION)                 250

TABLE 304            NORTH AMERICA: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2033 (USD MILLION)       250

TABLE 305            EUROPE: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2033 (USD MILLION) 251

TABLE 306            ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2033 (USD MILLION) 251

TABLE 307            LATIN AMERICA: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2033 (USD MILLION)       252

TABLE 308            MIDDLE EAST: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2033 (USD MILLION)       252

TABLE 309            GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2033 (USD MILLION)       252

TABLE 310            FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2023–2033 (USD MILLION) 254

TABLE 311            NORTH AMERICA: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2033 (USD MILLION)     254

TABLE 312            EUROPE: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2033 (USD MILLION)     255

TABLE 313            ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2033 (USD MILLION)     255

TABLE 314            LATIN AMERICA: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2033 (USD MILLION)     256

TABLE 315            MIDDLE EAST: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2033 (USD MILLION)     256

TABLE 316            GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2033 (USD MILLION)     256

TABLE 317            FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2033 (USD MILLION)          257

TABLE 318            NORTH AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2033 (USD MILLION)     258

TABLE 319            EUROPE: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2033 (USD MILLION)     258

TABLE 320            ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2033 (USD MILLION)     259

TABLE 321            LATIN AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2033 (USD MILLION)     259

TABLE 322            MIDDLE EAST: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2033 (USD MILLION)     260

TABLE 323            GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2033 (USD MILLION)     260

TABLE 324            FLOW CYTOMETRY MARKET, BY REGION, 2023–2033 (USD MILLION)       262

TABLE 325            NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            264

TABLE 326            NORTH AMERICA: FLOW CYTOMETRY MARKET, BY OFFERING,

2023–2033 (USD MILLION)            265

TABLE 327            NORTH AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION)            265

TABLE 328            NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION)                 265

TABLE 329            NORTH AMERICA: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            266

TABLE 330            NORTH AMERICA: CELL SORTERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            266

TABLE 331            NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            266

TABLE 332            NORTH AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            267

TABLE 333            NORTH AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         267

TABLE 334            NORTH AMERICA: DRUG DISCOVERY AND DEVELOPMENT MARKET,

BY TYPE, 2023–2033 (USD MILLION)         268

TABLE 335            NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         268

TABLE 336            NORTH AMERICA: FLOW CYTOMETRY MARKET, BY END USER,

2023–2033 (USD MILLION)            269

TABLE 337            US: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION)            270

TABLE 338            US: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         270

TABLE 339            US: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            271

TABLE 340            US: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            271

TABLE 341            US: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            271

TABLE 342            US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION)            272

TABLE 343            US: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION)              272

TABLE 344            US: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2033 (USD MILLION)            273

TABLE 345            US: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            273

TABLE 346            US: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE,

2023–2033 (USD MILLION)            274

TABLE 347            US: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION)            274

TABLE 348            CANADA: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION)     275

TABLE 349            CANADA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         276

TABLE 350            CANADA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            276

TABLE 351            CANADA: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            276

TABLE 352            CANADA: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            277

TABLE 353            CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            277

TABLE 354            CANADA: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            277

TABLE 355            CANADA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         278

TABLE 356            CANADA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            278

TABLE 357            CANADA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         279

TABLE 358            CANADA: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION)                279

TABLE 359            EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2023–2033 (USD MILLION)     281

TABLE 360            EUROPE: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION)     281

TABLE 361            EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         282

TABLE 362            EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            282

TABLE 363            EUROPE: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            282

TABLE 364            EUROPE: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            283

TABLE 365            EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            283

TABLE 366            EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            283

TABLE 367            EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION)                 284

TABLE 368            EUROPE: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            284

TABLE 369            EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION)                 285

TABLE 370            EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION)                285

TABLE 371            GERMANY: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION)     286

TABLE 372            GERMANY: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         287

TABLE 373            GERMANY: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            287

TABLE 374            GERMANY: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            287

TABLE 375            GERMANY: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            288

TABLE 376            GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            288

TABLE 377            GERMANY: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            288

TABLE 378            GERMANY: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         289

TABLE 379            GERMANY: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            289

TABLE 380            GERMANY: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         290

TABLE 381            GERMANY: FLOW CYTOMETRY MARKET, BY END USER,

2023–2033 (USD MILLION)            290

TABLE 382            UK: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION)            291

TABLE 383            UK: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         292

TABLE 384            UK: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            292

TABLE 385            UK: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            292

TABLE 386            UK: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            293

TABLE 387            UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION)            293

TABLE 388            UK: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION)              293

TABLE 389            UK: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2033 (USD MILLION)            294

TABLE 390            UK: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            294

TABLE 391            UK: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE,

2023–2033 (USD MILLION)            295

TABLE 392            UK: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION)            295

TABLE 393            FRANCE: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION)     296

TABLE 394            FRANCE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         296

TABLE 395            FRANCE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            297

TABLE 396            FRANCE: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            297

TABLE 397            FRANCE: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            297

TABLE 398            FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            298

TABLE 399            FRANCE: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            298

TABLE 400            FRANCE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         299

TABLE 401            FRANCE: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            299

TABLE 402            FRANCE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         300

TABLE 403            FRANCE: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION)                300

TABLE 404            ITALY: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION)     301

TABLE 405            ITALY: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         302

TABLE 406            ITALY: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            302

TABLE 407            ITALY: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            302

TABLE 408            ITALY: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            303

TABLE 409            ITALY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION)            303

TABLE 410            ITALY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION)              303

TABLE 411            ITALY: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         304

TABLE 412            ITALY: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            304

TABLE 413            ITALY: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE,

2023–2033 (USD MILLION)            305

TABLE 414            ITALY: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION)                305

TABLE 415            SPAIN: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION)     306

TABLE 416            SPAIN: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         307

TABLE 417            SPAIN: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            307

TABLE 418            SPAIN: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            307

TABLE 419            SPAIN: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            308

TABLE 420            SPAIN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION)            308

TABLE 421            SPAIN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION)              308

TABLE 422            SPAIN: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         309

TABLE 423            SPAIN: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            309

TABLE 424            SPAIN: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE,

2023–2033 (USD MILLION)            310

TABLE 425            SPAIN: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION)                310

TABLE 426            REST OF EUROPE: FLOW CYTOMETRY MARKET, BY OFFERING,

2023–2033 (USD MILLION)            311

TABLE 427            REST OF EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION)            312

TABLE 428            REST OF EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION)                 312

TABLE 429            REST OF EUROPE: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            312

TABLE 430            REST OF EUROPE: CELL SORTERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            313

TABLE 431            REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            313

TABLE 432            REST OF EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            313

TABLE 433            REST OF EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         314

TABLE 434            REST OF EUROPE: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION)                 314

TABLE 435            REST OF EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         315

TABLE 436            REST OF EUROPE: FLOW CYTOMETRY MARKET, BY END USER,

2023–2033 (USD MILLION)            315

TABLE 437            ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            318

TABLE 438            ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY OFFERING,

2023–2033 (USD MILLION)            318

TABLE 439            ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         319

TABLE 440            ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            319

TABLE 441            ASIA PACIFIC: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            319

TABLE 442            ASIA PACIFIC: CELL SORTERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            320

TABLE 443            ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            320

TABLE 444            ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            320

TABLE 445            ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         321

TABLE 446            ASIA PACIFIC: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            321

TABLE 447            ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         322

TABLE 448            ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER,

2023–2033 (USD MILLION)            322

TABLE 449            CHINA: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION)     323

TABLE 450            CHINA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         324

TABLE 451            CHINA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            324

TABLE 452            CHINA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            324

TABLE 453            CHINA: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            325

TABLE 454            CHINA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION)            325

TABLE 455            CHINA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION)              325

TABLE 456            CHINA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         326

TABLE 457            CHINA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            326

TABLE 458            CHINA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE,

2023–2033 (USD MILLION)            327

TABLE 459            CHINA: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION)                327

TABLE 460            JAPAN: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION)     328

TABLE 461            JAPAN: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         329

TABLE 462            JAPAN: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            329

TABLE 463            JAPAN: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            329

TABLE 464            JAPAN: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            330

TABLE 465            JAPAN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION)            330

TABLE 466            JAPAN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION)              330

TABLE 467            JAPAN: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         331

TABLE 468            JAPAN: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            331

TABLE 469            JAPAN: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE,

2023–2033 (USD MILLION)            332

TABLE 470            JAPAN: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION)                332

TABLE 471            INDIA: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION)     334

TABLE 472            INDIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         334

TABLE 473            INDIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            334

TABLE 474            INDIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            335

TABLE 475            INDIA: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            335

TABLE 476            INDIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION)            335

TABLE 477            INDIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION)              336

TABLE 478            INDIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         336

TABLE 479            INDIA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            337

TABLE 480            INDIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE,

2023–2033 (USD MILLION)            337

TABLE 481            INDIA: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION)                338

TABLE 482            AUSTRALIA: FLOW CYTOMETRY MARKET, BY OFFERING,

2023–2033 (USD MILLION)            339

TABLE 483            AUSTRALIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         339

TABLE 484            AUSTRALIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            340

TABLE 485            AUSTRALIA: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            340

TABLE 486            AUSTRALIA: CELL SORTERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            340

TABLE 487            AUSTRALIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)          341

TABLE 488            AUSTRALIA: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            341

TABLE 489            AUSTRALIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION)                 342

TABLE 490            AUSTRALIA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            342

TABLE 491            AUSTRALIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         343

TABLE 492            AUSTRALIA: FLOW CYTOMETRY MARKET, BY END USER,

2023–2033 (USD MILLION)            343

TABLE 493            SOUTH KOREA: FLOW CYTOMETRY MARKET, BY OFFERING,

2023–2033 (USD MILLION)            344

TABLE 494            SOUTH KOREA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         344

TABLE 495            SOUTH KOREA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            345

TABLE 496            SOUTH KOREA: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            345

TABLE 497            SOUTH KOREA: CELL SORTERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            345

TABLE 498            SOUTH KOREA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            346

TABLE 499            SOUTH KOREA: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            346

TABLE 500            SOUTH KOREA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         347

TABLE 501            SOUTH KOREA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            347

TABLE 502            SOUTH KOREA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         348

TABLE 503            SOUTH KOREA: FLOW CYTOMETRY MARKET, BY END USER,

2023–2033 (USD MILLION)            348

TABLE 504            SINGAPORE: FLOW CYTOMETRY MARKET, BY OFFERING,

2023–2033 (USD MILLION)            350

TABLE 505            SINGAPORE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         350

TABLE 506            SINGAPORE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            350

TABLE 507            SINGAPORE: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            351

TABLE 508            SINGAPORE: CELL SORTERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            351

TABLE 509            SINGAPORE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            351

TABLE 510            SINGAPORE: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            352

TABLE 511            SINGAPORE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         352

TABLE 512            SINGAPORE: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            353

TABLE 513            SINGAPORE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION)                 353

TABLE 514            SINGAPORE: FLOW CYTOMETRY MARKET, BY END USER,

2023–2033 (USD MILLION)            354

TABLE 515            INDONESIA: FLOW CYTOMETRY MARKET, BY OFFERING,

2023–2033 (USD MILLION)            355

TABLE 516            INDONESIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         355

TABLE 517            INDONESIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            356

TABLE 518            INDONESIA: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            356

TABLE 519            INDONESIA: CELL SORTERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            356

TABLE 520            INDONESIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            357

TABLE 521            INDONESIA: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            357

TABLE 522            INDONESIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         358

TABLE 523            INDONESIA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            358

TABLE 524            INDONESIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION)                 359

TABLE 525            INDONESIA: FLOW CYTOMETRY MARKET, BY END USER,

2023–2033 (USD MILLION)            359

TABLE 526            REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY OFFERING,

2023–2033 (USD MILLION)            360

TABLE 527            REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 360

TABLE 528            REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2033 (USD MILLION)            361

TABLE 529            REST OF ASIA PACIFIC: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            361

TABLE 530            REST OF ASIA PACIFIC: CELL SORTERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            361

TABLE 531            REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)          362

TABLE 532            REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            362

TABLE 533            REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 363

TABLE 534            REST OF ASIA PACIFIC: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE, 2023–2033 (USD MILLION)                 363

TABLE 535            REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 364

TABLE 536            REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER,

2023–2033 (USD MILLION)            364

TABLE 537            LATIN AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            365

TABLE 538            LATIN AMERICA: FLOW CYTOMETRY MARKET, BY OFFERING,

2023–2033 (USD MILLION)            366

TABLE 539            LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         366

TABLE 540            LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            366

TABLE 541            LATIN AMERICA: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            367

TABLE 542            LATIN AMERICA: CELL SORTERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            367

TABLE 543            LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            367

TABLE 544            LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            368

TABLE 545            LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         368

TABLE 546            LATIN AMERICA: DRUG DISCOVERY AND DEVELOPMENT MARKET,

BY TYPE, 2023–2033 (USD MILLION)         369

TABLE 547            LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         369

TABLE 548            LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER,

2023–2033 (USD MILLION)            370

TABLE 549            BRAZIL: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION)     371

TABLE 550            BRAZIL: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         371

TABLE 551            BRAZIL: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            371

TABLE 552            BRAZIL: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            372

TABLE 553            BRAZIL: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            372

TABLE 554            BRAZIL: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            372

TABLE 555            BRAZIL: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION)              373

TABLE 556            BRAZIL: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         373

TABLE 557            BRAZIL: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            374

TABLE 558            BRAZIL: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION)                 374

TABLE 559            BRAZIL: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION)                375

TABLE 560            MEXICO: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION)     376

TABLE 561            MEXICO: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         376

TABLE 562            MEXICO: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            376

TABLE 563            MEXICO: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            377

TABLE 564            MEXICO: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            377

TABLE 565            MEXICO: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            377

TABLE 566            MEXICO: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            378

TABLE 567            MEXICO: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         378

TABLE 568            MEXICO: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            379

TABLE 569            MEXICO: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION)                 379

TABLE 570            MEXICO: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION)                380

TABLE 571            REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY OFFERING,

2023–2033 (USD MILLION)            381

TABLE 572            REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 381

TABLE 573            REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS,

BY TYPE, 2023–2033 (USD MILLION)         381

TABLE 574            REST OF LATIN AMERICA: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)          382

TABLE 575            REST OF LATIN AMERICA: CELL SORTERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            382

TABLE 576            REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            382

TABLE 577            REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            383

TABLE 578            REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 383

TABLE 579            REST OF LATIN AMERICA: DRUG DISCOVERY AND DEVELOPMENT MARKET,

BY TYPE, 2023–2033 (USD MILLION)         384

TABLE 580            REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 384

TABLE 581            REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER,

2023–2033 (USD MILLION)            385

TABLE 582            MIDDLE EAST: FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)            386

TABLE 583            MIDDLE EAST: FLOW CYTOMETRY MARKET, BY OFFERING,

2023–2033 (USD MILLION)            386

TABLE 584            MIDDLE EAST: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         387

TABLE 585            MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            387

TABLE 586            MIDDLE EAST: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            387

TABLE 587            MIDDLE EAST: CELL SORTERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            388

TABLE 588            MIDDLE EAST: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            388

TABLE 589            MIDDLE EAST: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            388

TABLE 590            MIDDLE EAST: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         389

TABLE 591            MIDDLE EAST: DRUG DISCOVERY AND DEVELOPMENT MARKET,

BY TYPE, 2023–2033 (USD MILLION)         389

TABLE 592            MIDDLE EAST: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         390

TABLE 593            MIDDLE EAST: FLOW CYTOMETRY MARKET, BY END USER,

2023–2033 (USD MILLION)            390

TABLE 594            GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY COUNTRY,

2023–2033 (USD MILLION)          391

TABLE 595            GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY OFFERING,

2023–2033 (USD MILLION)            391

TABLE 596            GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION)            392

TABLE 597            GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INSTRUMENTS,

BY TYPE, 2023–2033 (USD MILLION)         392

TABLE 598            GCC COUNTRIES: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            392

TABLE 599            GCC COUNTRIES: CELL SORTERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            393

TABLE 600            GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            393

TABLE 601            GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            393

TABLE 602            GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         394

TABLE 603            GCC COUNTRIES: DRUG DISCOVERY AND DEVELOPMENT MARKET,

BY TYPE, 2023–2033 (USD MILLION)         394

TABLE 604            GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         395

TABLE 605            GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY END USER,

2023–2033 (USD MILLION)            395

TABLE 606            SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY OFFERING,

2023–2033 (USD MILLION)            396

TABLE 607            SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         396

TABLE 608            SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            397

TABLE 609            SAUDI ARABIA: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            397

TABLE 610            SAUDI ARABIA: CELL SORTERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            397

TABLE 611            SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            398

TABLE 612            SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            398

TABLE 613            SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         399

TABLE 614            SAUDI ARABIA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            399

TABLE 615            SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         400

TABLE 616            SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY END USER,

2023–2033 (USD MILLION)            400

TABLE 617            UAE: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION)     401

TABLE 618            UAE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES,

BY TYPE, 2023–2033 (USD MILLION)         402

TABLE 619            UAE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            402

TABLE 620            UAE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            402

TABLE 621            UAE: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            403

TABLE 622            UAE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023–2033 (USD MILLION)            403

TABLE 623            UAE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION)              403

TABLE 624            UAE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE,

2023–2033 (USD MILLION)            404

TABLE 625            UAE: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            404

TABLE 626            UAE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE,

2023–2033 (USD MILLION)            405

TABLE 627            UAE: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION)                405

TABLE 628            REST OF GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY OFFERING,

2023–2033 (USD MILLION)            406

TABLE 629            REST OF GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 407

TABLE 630            REST OF GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INSTRUMENTS,

BY TYPE, 2023–2033 (USD MILLION)         407

TABLE 631            REST OF GCC COUNTRIES: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            407

TABLE 632            REST OF GCC COUNTRIES: CELL SORTERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            408

TABLE 633            REST OF GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            408

TABLE 634            REST OF GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            408

TABLE 635            REST OF GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 409

TABLE 636            REST OF GCC COUNTRIES: DRUG DISCOVERY AND DEVELOPMENT MARKET,

BY TYPE, 2023–2033 (USD MILLION)         409

TABLE 637            REST OF GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 410

TABLE 638            REST OF GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY END USER,

2023–2033 (USD MILLION)            410

TABLE 639            REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY OFFERING,

2023–2033 (USD MILLION)            411

TABLE 640            REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION) 411

TABLE 641            REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INSTRUMENTS,

BY TYPE, 2023–2033 (USD MILLION)         412

TABLE 642            REST OF MIDDLE EAST: CELL ANALYZERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            412

TABLE 643          REST OF MIDDLE EAST: CELL SORTERS MARKET, BY PRICE RANGE,

2023–2033 (USD MILLION)            412

TABLE 644            REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            413

TABLE 645            REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY APPLICATION,

2023–2033 (USD MILLION)            413

TABLE 646            REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 414

TABLE 647            REST OF MIDDLE EAST: DRUG DISCOVERY AND DEVELOPMENT MARKET,

BY TYPE, 2023–2033 (USD MILLION)         414

TABLE 648            REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION) 415

TABLE 649            REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY END USER,

2023–2033 (USD MILLION)            415

TABLE 650            AFRICA: FLOW CYTOMETRY MARKET, BY OFFERING, 2023–2033 (USD MILLION)     417

TABLE 651            AFRICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2033 (USD MILLION)            417

TABLE 652            AFRICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE,

2023–2033 (USD MILLION)            417

TABLE 653            AFRICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            418

TABLE 654            AFRICA: CELL SORTERS MARKET, BY PRICE RANGE, 2023–2033 (USD MILLION)            418

TABLE 655            AFRICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,

2023–2033 (USD MILLION)            418

TABLE 656            AFRICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2023–2033 (USD MILLION)              419

TABLE 657            AFRICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2033 (USD MILLION)         419

TABLE 658            AFRICA: DRUG DISCOVERY AND DEVELOPMENT MARKET, BY TYPE,

2023–2033 (USD MILLION)            420

TABLE 659            AFRICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2023–2033 (USD MILLION)                 420

TABLE 660            AFRICA: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033 (USD MILLION)                421

TABLE 661            OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN

FLOW CYTOMETRY MARKET      422

TABLE 662            FLOW CYTOMETRY MARKET: DEGREE OF COMPETITION 425

TABLE 663            FLOW CYTOMETRY MARKET: PRODUCT & SERVICE FOOTPRINT     430

TABLE 664            FLOW CYTOMETRY MARKET: REGION FOOTPRINT       431

TABLE 665            FLOW CYTOMETRY MARKET: APPLICATION FOOTPRINT       432

TABLE 666            FLOW CYTOMETRY MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS               434

TABLE 667            FLOW CYTOMETRY MARKET: COMPETITIVE BENCHMARKING

OF KEY STARTUPS/SMES              435

TABLE 668            FLOW CYTOMETRY MARKET: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–MAY 2025               439

TABLE 669            FLOW CYTOMETRY MARKET: DEALS, JANUARY 2022–MAY 2025   440

TABLE 670            BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW   441

TABLE 671            BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES OFFERED               442

TABLE 672            BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES,

JANUARY 2021–MAY 2025               446

TABLE 673            BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–MAY 2025               447

TABLE 674            DANAHER CORPORATION: COMPANY OVERVIEW          449

TABLE 675            DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED               451

TABLE 676            DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025      453

TABLE 677            DANAHER CORPORATION: DEALS, JANUARY 2021–MAY 2025   453

TABLE 678            THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW          455

TABLE 679            THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED               456

TABLE 680            THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES,

JANUARY 2021–MAY 2025               457

TABLE 681            THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–MAY 2025               458

TABLE 682            AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW          459

TABLE 683            AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED               461

TABLE 684            AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025      462

TABLE 685            SONY CORPORATION: COMPANY OVERVIEW                 463

TABLE 686            SONY CORPORATION: PRODUCTS/SERVICES OFFERED             464

TABLE 687            SONY CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025               466

TABLE 688            SONY CORPORATION: DEALS, JANUARY 2021–MAY 2025              466

TABLE 689            BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW          467

TABLE 690            BIO-RAD LABORATORIES, INC.: PRODUCTS/ SERVICES/SOLUTIONS OFFERED              468

TABLE 691            BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025      469

TABLE 692            MILTENYI BIOTEC: COMPANY OVERVIEW                 470

TABLE 693            MILTENYI BIOTEC.: PRODUCTS/ SERVICES OFFERED             470

TABLE 694            ENZO BIOCHEM INC.: COMPANY OVERVIEW                 472

TABLE 695            ENZO BIOCHEM INC.: PRODUCTS/SERVICES OFFERED             473

TABLE 696            SYSMEX CORPORATION: COMPANY OVERVIEW                 475

TABLE 697            SYSMEX CORPORATION: PRODUCTS/SERVICES OFFERED             477

TABLE 698            SYSMEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025               477

TABLE 699            CYTEK BIOSCIENCES: COMPANY OVERVIEW                 478

TABLE 700            CYTEK BIOSCIENCES: PRODUCTS/ SERVICES OFFERED             480

TABLE 701            CYTEK BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025               481

TABLE 702            CYTEK BIOSCIENCES: DEALS, JANUARY 2021–MAY 2025              481

TABLE 703            BIOMÉRIEUX: COMPANY OVERVIEW      483

TABLE 704            BIOMÉRIEUX: PRODUCTS/SERVICES OFFERED                 484

TABLE 705            CYTONOME/ST, LLC: COMPANY OVERVIEW                 485

TABLE 706            CYTONOME/ST, LLC: PRODUCTS/ SERVICES OFFERED             485

TABLE 707            SARTORIUS AG: COMPANY OVERVIEW  486

TABLE 708            SARTORIUS AG: PRODUCTS/ SERVICES OFFERED             487

TABLE 709            UNION BIOMETRICA, INC.: COMPANY OVERVIEW          488

TABLE 710            UNION BIOMETRICA, INC.: PRODUCTS/ SERVICES OFFERED        488

TABLE 711            TAKARA BIO INC.: COMPANY OVERVIEW                 489

TABLE 712            TAKARA BIO INC.: PRODUCTS/ SERVICES OFFERED             491

TABLE 713            APOGEE FLOW SYSTEMS LTD.: COMPANY OVERVIEW          492

TABLE 714            STRATEDIGM, INC.: COMPANY OVERVIEW                 493

TABLE 715            NANOCELLECT BIOMEDICAL: COMPANY OVERVIEW          494

TABLE 716            BIOLEGEND, INC.: COMPANY OVERVIEW                 495

TABLE 717            ON-CHIP BIOTECHNOLOGIES CO., LTD.: COMPANY OVERVIEW   496

TABLE 718            NEXCELOM BIOSCIENCE LLC: COMPANY OVERVIEW          497

TABLE 719            BENNUBIO INC.: COMPANY OVERVIEW 498

TABLE 720            ORFLO TECHNOLOGIES: COMPANY OVERVIEW                 499

TABLE 721            BAY BIOSCIENCE LLC: COMPANY OVERVIEW                 500

TABLE 722            CYTOBUOY: COMPANY OVERVIEW         500

LIST OF FIGURES

FIGURE 1              FLOW CYTOMETRY MARKET: SEGMENTS COVERED            46

FIGURE 2              FLOW CYTOMETRY MARKET: YEARS CONSIDERED    47

FIGURE 3              FLOW CYTOMETRY MARKET: RESEARCH DESIGN                49

FIGURE 4              FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES          51

FIGURE 5              FLOW CYTOMETRY MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024  52

FIGURE 6              GLOBAL MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS

(BOTTOM-UP APPROACH), 2024                53

FIGURE 7              ILLUSTRATIVE EXAMPLE OF BECTON, DICKINSON AND COMPANY:

REVENUE ANALYSIS (2024)           53

FIGURE 8              MARKET VALIDATION FROM PRIMARY EXPERTS              55

FIGURE 9              SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH          55

FIGURE 10            FLOW CYTOMETRY MARKET: CAGR PROJECTIONS, 2025–2033               57

FIGURE 11            FLOW CYTOMETRY MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    58

FIGURE 12            DATA TRIANGULATION METHODOLOGY                 59

FIGURE 13            FLOW CYTOMETRY MARKET, BY OFFERING, 2025 VS. 2033 (USD MILLION)      62

FIGURE 14           FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2025 VS. 2033 (USD MILLION)      63

FIGURE 15            FLOW CYTOMETRY MARKET, BY APPLICATION, 2025 VS. 2033 (USD MILLION)      63

FIGURE 16            FLOW CYTOMETRY MARKET, BY END USER, 2025 VS. 2033 (USD MILLION)      64

FIGURE 17            FLOW CYTOMETRY MARKET: GEOGRAPHIC ANALYSIS            65

FIGURE 18            LAUNCH OF TECHNOLOGICALLY ADVANCED FLOW CYTOMETRY

PRODUCTS TO DRIVE MARKET 66

FIGURE 19            CELL-BASED FLOW CYTOMETRY ACCOUNTED FOR LARGER SHARE

OF MARKET IN NORTH AMERICA IN 2024              67

FIGURE 20            ACADEMIC & RESEARCH INSTITUTES TO LEAD MARKET DURING FORECAST PERIOD    67

FIGURE 21            CHINA TO BE FASTEST-GROWING COUNTRY-LEVEL MARKET

DURING FORECAST PERIOD       68

FIGURE 22            FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS,

OPPORTUNITIES, AND CHALLENGES     69

FIGURE 23            RISING USE OF FLOW CYTOMETRY IN CLINICAL APPLICATIONS 76

FIGURE 24            AVERAGE SELLING PRICE OF REAGENTS AND CONSUMABLES,

BY KEY PLAYER, 2024 (USD)         78

FIGURE 25            AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2024 (USD)        78

FIGURE 26            AVERAGE SELLING PRICE OF INSTRUMENTS, BY REGION, 2024 (USD MILLION)    79

FIGURE 27            AVERAGE SELLING PRICE OF REAGENTS AND CONSUMABLES,

BY REGION, 2024 (USD MILLION)              80

FIGURE 28            FLOW CYTOMETRY MARKET: VALUE CHAIN ANALYSIS            81

FIGURE 29            FLOW CYTOMETRY MARKET: ECOSYSTEM ANALYSIS            83

FIGURE 30            FLOW CYTOMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS           89

FIGURE 31            FLOW CYTOMETRY MARKET: INFLUENCE OF KEY STAKEHOLDERS

ON BUYING PROCESS    92

FIGURE 32            FLOW CYTOMETRY MARKET: KEY BUYING CRITERIA, BY END USER                93

FIGURE 33            PATENT APPLICATIONS IN FLOW CYTOMETRY MARKET,

JANUARY 2014–DECEMBER 2024 97

FIGURE 34            FUNDING AND NUMBER OF DEALS IN FLOW CYTOMETRY MARKET, 2022–2025              101

FIGURE 35            FLOW CYTOMETRY MARKET: AI USE CASES                 108

FIGURE 36            NUMBER OF ORGAN TRANSPLANTS IN US (2024)                 235

FIGURE 37            NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT          264

FIGURE 38            ASIA PACIFIC: FLOW CYTOMETRY MARKET SNAPSHOT          317

FIGURE 39            REVENUE ANALYSIS OF KEY PLAYERS IN FLOW CYTOMETRY MARKET,

2022–2024 (USD MILLION)            424

FIGURE 40            FLOW CYTOMETRY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2024      425

FIGURE 41            FLOW CYTOMETRY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024         428

FIGURE 42            FLOW CYTOMETRY MARKET: COMPANY FOOTPRINT       429

FIGURE 43            FLOW CYTOMETRY MARKET: COMPANY EVALUATION MATRIX

(STARTUPS/SMES), 2024                433

FIGURE 44            EV/EBITDA OF KEY PLAYERS      436

FIGURE 45            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY PLAYERS  436

FIGURE 46            FLOW CYTOMETRY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS

OF CELL SORTERS           437

FIGURE 47            FLOW CYTOMETRY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS

OF CELL ANALYZERS     438

FIGURE 48            BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024)      442

FIGURE 49            DANAHER CORPORATION: COMPANY SNAPSHOT (2024)             450

FIGURE 50            THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)             456

FIGURE 51            AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)             460

FIGURE 52            SONY CORPORATION: COMPANY SNAPSHOT (2024)    464

FIGURE 53            BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)             468

FIGURE 54            ENZO BIOCHEM INC.: COMPANY SNAPSHOT (2024)    472

FIGURE 55            SYSMEX CORPORATION: COMPANY SNAPSHOT (2024)    476

FIGURE 56            CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2024)    479

FIGURE 57            BIOMÉRIEUX: COMPANY SNAPSHOT (2024)                 484

FIGURE 58            SARTORIUS AG: COMPANY SNAPSHOT (2024)                 487

FIGURE 59            TAKARA BIO INC.: COMPANY SNAPSHOT (2024)                 490

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧